Provided by Tiger Fintech (Singapore) Pte. Ltd.

Birth Control

1,224.93
+15.561.29%
Number of Gainers:3
Number of Losers:1
Number of Flat:2
PE:- -
High:1,240.67
Open:1,210.07
Low:1,208.71
Close:1,209.37
Loading ...

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Teva Pharmaceutical (TEVA) and Incyte (INCY)

TIPRANKS
·
2 hours ago

BRIEF-Teva Launches Spring Summer 2025 Collection Designed For Playground Earth

Reuters
·
04 Mar

Teva Launches Spring Summer 2025 Collection; Designed for Playground Earth

THOMSON REUTERS
·
04 Mar

Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey
·
02 Mar

Sanofi's Positive Duvakitug Data Raises Market Questions for Teva Pharmaceutical Industries (NYSE:TEVA)

Simply Wall St.
·
02 Mar

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey
·
27 Feb

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

THOMSON REUTERS
·
27 Feb

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

GlobeNewswire
·
27 Feb

Analysts Are Bullish on These Healthcare Stocks: Sarepta Therapeutics (SRPT), MannKind (MNKD)

TIPRANKS
·
27 Feb

MannKind Corporation Reports Strong 2024 Financial Growth

TIPRANKS
·
27 Feb

BRIEF-MannKind Files For Mixed Shelf - SEC Filing

Reuters
·
27 Feb

MannKind files automatic mixed securities shelf

TIPRANKS
·
27 Feb

MannKind Corp Files for Mixed Shelf - SEC Filing

THOMSON REUTERS
·
27 Feb

MannKind : Sales Agreement Prospectus Covers Offering of up to $200 Mln of Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
27 Feb

BRIEF-MannKind Q4 Pretax Profit USD 8.445 Million

Reuters
·
27 Feb

MannKind Q4 Net Income USD 7.422 Million

THOMSON REUTERS
·
27 Feb